Literature DB >> 15090766

Identification of modifiable factors that affect the genetic diversity of the transmitted HIV-1 population.

Manish Sagar1, Ludo Lavreys, Jared M Baeten, Barbra A Richardson, Kishorchandra Mandaliya, Jeckoniah O Ndinya-Achola, Joan K Kreiss, Julie Overbaugh.   

Abstract

BACKGROUND: Our previous studies have shown that the majority of African women were infected with multiple HIV-1 genetic variants, while in the remaining women only a single viral genotype was detected early in infection. Infection with multiple viral variants was associated with higher plasma HIV-1 RNA levels and faster CD4 T-cell decline.
METHOD: Socio-behavioral characteristics, use of hormonal contraceptives, and the presence of sexually transmitted diseases were prospectively assessed at approximately monthly intervals around the time of HIV-1 acquisition in female sex workers in Kenya. We assessed the relationship between these factors and HIV-1 genetic complexity early in infection.
RESULTS: One hundred and fifty-six women were included in this analysis, of whom 89 had multiple viral genotypes and 67 had a single genotype at primary infection. Women with multiple variants were more likely to have a genital tract infection [odds ratio (OR), 4.7; 95% confidence interval (CI), 1.4-18.1] or to be using hormonal contraceptives (OR, 2.7; 95% CI, 1.3-5.6) at the time of their infection than those with a single variant. In multivariate analyses, these factors were independent predictors of early HIV-1 genetic complexity, and the presence of multiple viral variants early in infection remained significantly associated with a higher steady state plasma HIV-1 RNA level.
CONCLUSION: The presence of genital tract infections and hormonal contraceptive use at the time of transmission were associated with the acquisition of multiple HIV-1 variants.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15090766     DOI: 10.1097/00002030-200403050-00005

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  31 in total

1.  Short communication decreased incidence of dual infections in South african subtype C-infected women compared to a cohort ten years earlier.

Authors:  Zenda Woodman; Koleka Mlisana; Florette Treurnicht; Melissa-Rose Abrahams; Ruwayida Thebus; Salim Abdool Karim; Carolyn Williamson
Journal:  AIDS Res Hum Retroviruses       Date:  2011-02-09       Impact factor: 2.205

2.  Effect of hormonal contraceptive use on HIV progression in female HIV seroconverters in Rakai, Uganda.

Authors:  Chelsea B Polis; Maria J Wawer; Noah Kiwanuka; Oliver Laeyendecker; Joseph Kagaayi; Tom Lutalo; Fred Nalugoda; Godfrey Kigozi; David Serwadda; Ronald H Gray
Journal:  AIDS       Date:  2010-07-31       Impact factor: 4.177

Review 3.  The Antibody Response against HIV-1.

Authors:  Julie Overbaugh; Lynn Morris
Journal:  Cold Spring Harb Perspect Med       Date:  2012-01       Impact factor: 6.915

4.  Hormonal contraceptive use and HIV disease progression among women in Uganda and Zimbabwe.

Authors:  Charles S Morrison; Pai-Lien Chen; Immaculate Nankya; Anne Rinaldi; Barbara Van Der Pol; Yun-Rong Ma; Tsungai Chipato; Roy Mugerwa; Megan Dunbar; Eric Arts; Robert A Salata
Journal:  J Acquir Immune Defic Syndr       Date:  2011-06-01       Impact factor: 3.731

5.  Previously transmitted HIV-1 strains are preferentially selected during subsequent sexual transmissions.

Authors:  Andrew D Redd; Aleisha N Collinson-Streng; Nikolaos Chatziandreou; Caroline E Mullis; Oliver Laeyendecker; Craig Martens; Stacy Ricklefs; Noah Kiwanuka; Phyu Hninn Nyein; Tom Lutalo; Mary K Grabowski; Xiangrong Kong; Jordyn Manucci; Nelson Sewankambo; Maria J Wawer; Ronald H Gray; Stephen F Porcella; Anthony S Fauci; Manish Sagar; David Serwadda; Thomas C Quinn
Journal:  J Infect Dis       Date:  2012-09-19       Impact factor: 5.226

6.  Hormonal contraceptive use and risk of HIV-1 disease progression.

Authors:  Renee Heffron; Nelly Mugo; Kenneth Ngure; Connie Celum; Deborah Donnell; Edwin Were; Helen Rees; James Kiarie; Jared M Baeten
Journal:  AIDS       Date:  2013-01-14       Impact factor: 4.177

7.  Human immunodeficiency virus type 1 (HIV-1) diversity at time of infection is not restricted to certain risk groups or specific HIV-1 subtypes.

Authors:  Manish Sagar; Erin Kirkegaard; E Michelle Long; Connie Celum; Susan Buchbinder; Eric S Daar; Julie Overbaugh
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

Review 8.  HIV molecular epidemiology: transmission and adaptation to human populations.

Authors:  Zenda Woodman; Carolyn Williamson
Journal:  Curr Opin HIV AIDS       Date:  2009-07       Impact factor: 4.283

Review 9.  HIV transmission biology: translation for HIV prevention.

Authors:  Keshet Ronen; Amit Sharma; Julie Overbaugh
Journal:  AIDS       Date:  2015-11       Impact factor: 4.177

10.  Cross-subtype neutralization sensitivity despite monoclonal antibody resistance among early subtype A, C, and D envelope variants of human immunodeficiency virus type 1.

Authors:  Catherine A Blish; Zahra Jalalian-Lechak; Stephanie Rainwater; Minh-An Nguyen; Ozge C Dogan; Julie Overbaugh
Journal:  J Virol       Date:  2009-05-27       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.